Published in J Cell Biol on July 01, 1995
Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest (1997) 3.76
Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am J Pathol (1997) 2.17
Role of beta2-integrins for homing and neovascularization capacity of endothelial progenitor cells. J Exp Med (2004) 2.04
The biology of PECAM-1. J Clin Invest (1997) 2.01
Stepping out of the flow: capillary extravasation in cancer metastasis. Clin Exp Metastasis (2007) 1.68
Soluble domain 1 of platelet-endothelial cell adhesion molecule (PECAM) is sufficient to block transendothelial migration in vitro and in vivo. J Exp Med (1997) 1.60
Involvement of integrin alpha(v)beta(3) and cell adhesion molecule L1 in transendothelial migration of melanoma cells. Mol Biol Cell (2001) 1.51
Human neural cell adhesion molecule L1 and rat homologue NILE are ligands for integrin alpha v beta 3. J Cell Biol (1996) 1.50
Blood vessels form a migratory scaffold in the rostral migratory stream. J Comp Neurol (2009) 1.36
PECAM-1 (CD31) expression modulates bleeding time in vivo. Am J Pathol (2000) 1.36
PECAM-1: conflicts of interest in inflammation. Life Sci (2010) 1.30
Functional roles for PECAM-1 (CD31) and VE-cadherin (CD144) in tube assembly and lumen formation in three-dimensional collagen gels. Am J Pathol (1999) 1.29
A role for the alphavbeta3 integrin in the transmigration of monocytes. J Cell Biol (1998) 1.23
Presentation of integrins on leukocyte microvilli: a role for the extracellular domain in determining membrane localization. J Cell Biol (1997) 1.21
CD9 is associated with leukemia inhibitory factor-mediated maintenance of embryonic stem cells. Mol Biol Cell (2002) 1.17
Role of platelet adhesion in homeostasis and immunopathology. Mol Pathol (1997) 1.16
Lack of platelet endothelial cell adhesion molecule-1 attenuates foreign body inflammation because of decreased angiogenesis. Am J Pathol (2003) 1.16
Cell adhesion molecules in the pathogenesis of and host defence against microbial infection. Mol Pathol (1999) 1.14
Future innovations in anti-platelet therapies. Br J Pharmacol (2008) 1.13
Hyperglycemia-induced vasculopathy in the murine vitelline vasculature: correlation with PECAM-1/CD31 tyrosine phosphorylation state. Am J Pathol (1999) 1.09
Integrin-associated protein immunoglobulin domain is necessary for efficient vitronectin bead binding. J Cell Biol (1996) 1.08
Platelet-endothelial cell adhesion molecule-1 (PECAM-1/CD31) tyrosine phosphorylation state changes during vasculogenesis in the murine conceptus. Am J Pathol (1997) 1.07
Expression of cell adhesion molecules in oesophageal carcinoma and its prognostic value. J Clin Pathol (2005) 1.06
Thrombospondin-1, a natural inhibitor of angiogenesis, regulates platelet-endothelial cell adhesion molecule-1 expression and endothelial cell morphogenesis. Mol Biol Cell (1997) 1.06
PECAM-1: regulator of endothelial junctional integrity. Cell Tissue Res (2014) 1.05
PECAM-1/CD31 trans-homophilic binding at the intercellular junctions is independent of its cytoplasmic domain; evidence for heterophilic interaction with integrin alphavbeta3 in Cis. Mol Biol Cell (2000) 1.04
Down-regulation of platelet endothelial cell adhesion molecule-1 results in thrombospondin-1 expression and concerted regulation of endothelial cell phenotype. Mol Biol Cell (1998) 1.03
Interaction of CD31 with a heterophilic counterreceptor involved in downregulation of human T cell responses. J Exp Med (1996) 1.01
A new role for the muscle repair protein dysferlin in endothelial cell adhesion and angiogenesis. Arterioscler Thromb Vasc Biol (2010) 1.01
Synthetic RGDS peptide attenuates lipopolysaccharide-induced pulmonary inflammation by inhibiting integrin signaled MAP kinase pathways. Respir Res (2009) 1.00
Shedding of PECAM-1 during HIV infection: a potential role for soluble PECAM-1 in the pathogenesis of NeuroAIDS. J Leukoc Biol (2006) 0.99
Changed colonic profile of P-selectin, platelet-endothelial cell adhesion molecule-1 (PECAM-1), intercellular adhesion molecule-1 (ICAM-1), ICAM-2, and ICAM-3 in inflammatory bowel disease. Clin Exp Immunol (2000) 0.99
Cell migration from baby to mother. Cell Adh Migr (2007) 0.99
Identification of gene function and functional pathways by systemic plasmid-based ribozyme targeting in adult mice. Proc Natl Acad Sci U S A (2002) 0.98
Cell adhesion and angiogenesis. J Clin Invest (1997) 0.98
HEMCAM, an adhesion molecule expressed by c-kit+ hemopoietic progenitors. J Cell Biol (1996) 0.97
The expression of platelet endothelial cell adhesion molecule-1 in mouse primordial germ cells during their migration and early gonadal formation. Histochem Cell Biol (2003) 0.94
Cell-cell interactions in synovitis. Endothelial cells and immune cell migration. Arthritis Res (2000) 0.93
Localization of cysteine protease, cathepsin S, to the surface of vascular smooth muscle cells by association with integrin alphanubeta3. Am J Pathol (2006) 0.93
Role of CD31/platelet endothelial cell adhesion molecule-1 expression in in vitro and in vivo growth and differentiation of human breast cancer cells. Am J Pathol (2003) 0.91
Integrin activation by regulated dimerization and oligomerization of platelet endothelial cell adhesion molecule (PECAM)-1 from within the cell. J Cell Biol (2001) 0.90
Human aging and CD31+ T-cell number, migration, apoptotic susceptibility, and telomere length. J Appl Physiol (1985) (2010) 0.90
CD38 binding to human myeloid cells is mediated by mouse and human CD31. Biochem J (1998) 0.89
CD31 exhibits multiple roles in regulating T lymphocyte trafficking in vivo. J Immunol (2012) 0.87
Nov/CCN3 regulates long-term repopulating activity of murine hematopoietic stem cells via integrin αvβ3. Int J Hematol (2014) 0.86
Differential modulation of cadherin-mediated cell-cell adhesion by platelet endothelial cell adhesion molecule-1 isoforms through activation of extracellular regulated kinases. Mol Biol Cell (2000) 0.86
PECAM-1 isoforms, eNOS and endoglin axis in regulation of angiogenesis. Clin Sci (Lond) (2015) 0.85
Angiogenesis in male breast cancer. World J Surg Oncol (2005) 0.82
Tyrosine residue in exon 14 of the cytoplasmic domain of platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) regulates ligand binding specificity. J Cell Biol (1997) 0.82
Context- and cell-dependent effects of Delta-like 4 targeting in the bone marrow microenvironment. PLoS One (2012) 0.80
Induction of ICAM-1 and VCAM-1 on the mouse lingual lymphatic endothelium with TNF-alpha. Acta Histochem Cytochem (2008) 0.80
Integrins modulate the infection efficiency of West Nile virus into cells. J Gen Virol (2013) 0.79
Inhibition of a novel specific neuroglial integrin signaling pathway increases STAT3-mediated CNTF expression. Cell Commun Signal (2013) 0.79
Addressing the Inflammatory Response to Clinically Relevant Polymers by Manipulating the Host Response Using ITIM Domain-Containing Receptors. Polymers (Basel) (2014) 0.78
Mitral and tufted cells are potential cellular targets of nitration in the olfactory bulb of aged mice. PLoS One (2013) 0.78
cDNA cloning reveals two mouse beta5 integrin transcripts distinct in cytoplasmic domains as a result of alternative splicing. Biochem J (1998) 0.77
The matricellular protein CCN5 regulates podosome function via interaction with integrin αvβ 3. J Cell Commun Signal (2014) 0.77
Neuron-derived neurotrophic factor functions as a novel modulator that enhances endothelial cell function and revascularization processes. J Biol Chem (2014) 0.77
Integrin-dependent neutrophil migration in the injured mouse cornea. Exp Eye Res (2014) 0.77
Regulation of trophoblast beta1-integrin expression by contact with endothelial cells. Cell Commun Signal (2004) 0.76
Genetic update on inflammatory factors in ulcerative colitis: Review of the current literature. World J Gastrointest Pathophysiol (2014) 0.76
Structural Basis for Human PECAM-1-Mediated Trans-homophilic Cell Adhesion. Sci Rep (2016) 0.75
TOP2A, GGH, and PECAM1 are associated with hematogenous, lymph node, and peritoneal recurrence in stage II/III gastric cancer patients enrolled in the ACTS-GC study. Oncotarget (2017) 0.75
Integrins: versatility, modulation, and signaling in cell adhesion. Cell (1992) 34.06
Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell (1994) 27.85
Integrins: a family of cell surface receptors. Cell (1987) 21.14
Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem (1984) 18.48
New perspectives in cell adhesion: RGD and integrins. Science (1987) 18.41
Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science (1994) 12.83
Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell (1994) 9.51
VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu Rev Immunol (1990) 7.62
PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science (1990) 5.28
The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus. Cell (1990) 4.83
PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med (1993) 4.81
Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature (1990) 4.67
Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression. Cancer Res (1990) 4.22
Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor. Proc Natl Acad Sci U S A (1987) 4.17
Evidence for a role of the integrin VLA-4 in lympho-hemopoiesis. J Exp Med (1991) 3.21
The dynamic regulation of integrin adhesiveness. Curr Biol (1994) 3.21
Involvement of integrin alpha V gene expression in human melanoma tumorigenicity. J Clin Invest (1992) 2.92
Mapping of antigenic and functional epitopes on the alpha- and beta-subunits of two related mouse glycoproteins involved in cell interactions, LFA-1 and Mac-1. J Exp Med (1983) 2.78
Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular development. Development (1994) 2.71
EndoCAM: a novel endothelial cell-cell adhesion molecule. J Cell Biol (1990) 2.71
Differential utilization of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T lymphocytes. J Immunol (1991) 2.69
Fibronectin and vitronectin regulate the organization of their respective Arg-Gly-Asp adhesion receptors in cultured human endothelial cells. J Cell Biol (1988) 2.64
A monoclonal antibody against an activation epitope on mouse integrin chain beta 1 blocks adhesion of lymphocytes to the endothelial integrin alpha 6 beta 1. Proc Natl Acad Sci U S A (1993) 2.40
CD31 expressed on distinctive T cell subsets is a preferential amplifier of beta 1 integrin-mediated adhesion. J Exp Med (1992) 2.38
Integrin beta 1- and beta 3-mediated endothelial cell migration is triggered through distinct signaling mechanisms. J Cell Biol (1993) 2.38
Embryonic lethalities and endothelial tumors in chimeric mice expressing polyoma virus middle T oncogene. Cell (1988) 2.36
The proteins encoded by the VpreB and lambda 5 pre-B cell-specific genes can associate with each other and with mu heavy chain. J Exp Med (1990) 2.22
Role of the alpha v beta 3 integrin in human melanoma cell invasion. Proc Natl Acad Sci U S A (1992) 2.18
Vitronectin and its receptors. Curr Opin Cell Biol (1993) 2.17
Molecular cloning of murine intercellular adhesion molecule (ICAM-1). EMBO J (1989) 2.10
The vitronectin receptor alpha v beta 3 binds fibronectin and acts in concert with alpha 5 beta 1 in promoting cellular attachment and spreading on fibronectin. J Cell Biol (1990) 2.07
Molecular and functional aspects of PECAM-1/CD31. Immunol Today (1994) 2.04
Isolation of a highly specific ligand for the alpha 5 beta 1 integrin from a phage display library. J Cell Biol (1994) 1.80
Requirement of the integrin beta 3 subunit for carcinoma cell spreading or migration on vitronectin and fibrinogen. J Cell Biol (1992) 1.78
A novel integrin specificity exemplified by binding of the alpha v beta 5 integrin to the basic domain of the HIV Tat protein and vitronectin. J Cell Biol (1993) 1.74
Integrin-mediated cell adhesion: the extracellular face. J Biol Chem (1994) 1.66
Leukocyte migration and adhesion. Adv Immunol (1995) 1.62
Murine platelet endothelial cell adhesion molecule (PECAM-1)/CD31 modulates beta 2 integrins on lymphokine-activated killer cells. Eur J Immunol (1993) 1.58
Integrin expression in human melanoma cells with differing invasive and metastatic properties. Clin Exp Metastasis (1992) 1.57
Platelet/endothelial cell adhesion molecule-1 (CD31)-mediated cellular aggregation involves cell surface glycosaminoglycans. J Biol Chem (1993) 1.55
A heterophilic adhesion mechanism for platelet/endothelial cell adhesion molecule 1 (CD31). J Exp Med (1992) 1.55
The induction of 72-kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent. J Cell Biol (1994) 1.52
Integrin (alpha v beta 3)-ligand interaction. Identification of a heterodimeric RGD binding site on the vitronectin receptor. J Biol Chem (1990) 1.52
Mapping the homotypic binding sites in CD31 and the role of CD31 adhesion in the formation of interendothelial cell contacts. J Cell Biol (1995) 1.38
Activated endothelium binds lymphocytes through a novel binding site in the alternately spliced domain of vascular cell adhesion molecule-1. J Exp Med (1992) 1.30
Molecular cloning and adhesive properties of murine platelet/endothelial cell adhesion molecule 1. Proc Natl Acad Sci U S A (1993) 1.25
Deletions in the cytoplasmic domain of platelet-endothelial cell adhesion molecule-1 (PECAM-1, CD31) result in changes in ligand binding properties. J Cell Biol (1994) 1.23
Studies of lymphocyte transendothelial migration: analysis of migrated cell phenotypes with regard to CD31 (PECAM-1), CD45RA and CD45RO. Immunology (1993) 1.22
The vitronectin receptor serves as an accessory molecule for the activation of a subset of gamma/delta T cells. J Exp Med (1991) 1.21
Generation and characterization of purified adherent lymphokine-activated killer cells in mice. J Immunol (1989) 1.19
Thymocyte clones from 14-day mouse embryos. I. State of T cell receptor genes, surface markers, and growth requirements. J Exp Med (1987) 1.18
Approaches to studying cell adhesion molecules in angiogenesis. Trends Cell Biol (1995) 1.16
Bispecific single chain molecules (Janusins) target cytotoxic lymphocytes on HIV infected cells. EMBO J (1991) 1.13
Interactions between cancer cells and the microvasculature: a rate-regulator for metastasis. Clin Exp Metastasis (1989) 1.12
Adhesive properties of the beta 3 integrins: comparison of GP IIb-IIIa and the vitronectin receptor individually expressed in human melanoma cells. J Cell Biol (1991) 1.07
Platelet endothelial cell adhesion molecule (CD31). Curr Top Microbiol Immunol (1993) 1.07
Integrin expression in human melanoma cell lines: heterogeneity of vitronectin receptor composition and function. Int J Cancer (1991) 1.06
Functional domains of cell adhesion molecules. Curr Opin Cell Biol (1992) 1.05
A murine very late activation antigen-like extracellular matrix receptor involved in CD2- and lymphocyte function-associated antigen-1-independent killer-target cell interaction. J Immunol (1990) 1.01
IL-3-dependent mast cells attach to plate-bound vitronectin. Demonstration of augmented proliferation in response to signals transduced via cell surface vitronectin receptors. J Immunol (1992) 1.00
The mouse vitronectin receptor is a T cell activation antigen. J Exp Med (1991) 0.98
Expression and function of fibronectin binding integrins on rat mast cells. Int Immunol (1995) 0.97
Evidence that a non-RGD domain in rat osteopontin is involved in cell attachment. J Bone Miner Res (1993) 0.94
Lymphocyte migration across high endothelium is associated with increases in alpha 4 beta 1 integrin (VLA-4) affinity. J Cell Sci (1993) 0.94
Murine T cells express a cell surface receptor for multiple extracellular matrix proteins. Identification and characterization with monoclonal antibodies. J Exp Med (1989) 0.92
Mammalian tissue distribution of a large heparan sulfate proteoglycan detected by monoclonal antibodies. Matrix (1989) 0.92
Labeling of integrin alpha v beta 3 with 58Co(III). Evidence of metal ion coordination sphere involvement in ligand binding. J Biol Chem (1991) 0.92
Adhesive interactions in angiogenesis and metastasis. Pharmacol Ther (1992) 0.90
Integrins: a review of their structure and mechanisms of ligand binding. Symp Soc Exp Biol (1993) 0.89
Antigen-independent T cell activation mediated by a very late activation antigen-like extracellular matrix receptor. Eur J Immunol (1991) 0.88
Expression of vitronectin receptor on human NK cells and its role in protein phosphorylation, cytokine production, and cell proliferation. J Immunol (1995) 0.86
Gene transfer demonstrates that the V gamma 1.1C gamma 4V delta 6C delta T cell receptor is essential for autoreactivity. J Immunol (1992) 0.85
Constitutive alpha V beta 3 integrin-mediated adhesion of human lymphoid B cells to vitronectin substrate. Cell Immunol (1995) 0.84
Lymphocyte recirculation and homing: roles of adhesion molecules and chemoattractants. Trends Cell Biol (1994) 0.80
Structure and function of endothelial cell integrins. Haemostasis (1988) 0.80
Integrin alpha 4 beta 1: its structure, ligand-binding specificity and role in lymphocyte-endothelial cell interactions. Chem Immunol (1991) 0.80
Adhesion molecules involved in the trafficking of normal and malignant leukocytes. Invasion Metastasis (1992) 0.79
Cloning and sequencing of mouse VCAM-1 cDNA. Gene (1993) 0.78
Production and secretion of recombinant soluble CD3 polypeptides by myeloma-derived transfectant clones. Immunol Lett (1989) 0.76
Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial. J Clin Oncol (2005) 5.82
Dissociation of Madin-Darby canine kidney epithelial cells by the monoclonal antibody anti-arc-1: mechanistic aspects and identification of the antigen as a component related to uvomorulin. J Cell Biol (1985) 3.77
Marching at the front and dragging behind: differential alphaVbeta3-integrin turnover regulates focal adhesion behavior. J Cell Biol (2001) 3.28
Endocytic vesicles move at the tips of actin tails in cultured mast cells. Nat Cell Biol (1999) 3.17
Actin dynamics in living mammalian cells. J Cell Sci (1998) 2.86
Clinical and genetic studies of Birt-Hogg-Dubé syndrome. J Med Genet (2002) 2.65
Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct. Am J Surg Pathol (2000) 2.58
Cell-cell interaction and polarity of epithelial cells: specific perturbation using a monoclonal antibody. Cell (1983) 2.56
The natural history of hereditary pancreatitis: a national series. Gut (2008) 2.33
Risk of pancreatic adenocarcinoma in chronic pancreatitis. Gut (2002) 2.21
Complement-dependent B-cell activation by cobra venom factor and other mitogens? J Exp Med (1974) 1.97
Assessment of complications of EUS-guided fine-needle aspiration. Gastrointest Endosc (2001) 1.94
Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement. N Engl J Med (1983) 1.85
Actin-dependent lamellipodia formation and microtubule-dependent tail retraction control-directed cell migration. Mol Biol Cell (2000) 1.84
Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial. Ann Oncol (2013) 1.82
Effects of interferon on antibody synthesis in vitro. J Immunol (1974) 1.73
Characterization of plasminogen activators from normal human breast and colon and from breast and colon carcinomas. Int J Cancer (1984) 1.72
JAM-2, a novel immunoglobulin superfamily molecule, expressed by endothelial and lymphatic cells. J Biol Chem (2000) 1.69
Glycoprotein IIb-IIIa is expressed on avian multilineage hematopoietic progenitor cells. Blood (1999) 1.67
High expression level of alpha 6 integrin in human breast carcinoma is correlated with reduced survival. Cancer Res (1995) 1.65
Pathophysiology of endotoxin shock in the primate. Am J Obstet Gynecol (1970) 1.65
Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin. BMJ (1991) 1.65
Value of endoscopic ultrasound guided fine needle aspiration biopsy in the diagnosis of solid pancreatic masses. Gut (2000) 1.63
Leukocyte migration and adhesion. Adv Immunol (1995) 1.62
Heterogeneity of endothelial junctions is reflected by differential expression and specific subcellular localization of the three JAM family members. Blood (2001) 1.61
Murine platelet endothelial cell adhesion molecule (PECAM-1)/CD31 modulates beta 2 integrins on lymphokine-activated killer cells. Eur J Immunol (1993) 1.58
Hepatic arterial chemoembolization with streptozotocin in patients with metastatic digestive endocrine tumours. Eur J Gastroenterol Hepatol (2000) 1.57
Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo. J Exp Med (1998) 1.57
[Pancreatic lesions in von Hippel-Lindau disease]. Ann Pathol (2000) 1.50
Characterization and function of T cell Fc gamma receptor. Immunol Rev (1981) 1.50
Differential diagnosis between chronic pancreatitis and pancreatic cancer: value of the detection of KRAS2 mutations in circulating DNA. Br J Cancer (2002) 1.47
Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma. Blood (1984) 1.44
The parting of the endothelium: miracle, or simply a junctional affair? J Cell Sci (2000) 1.42
Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study. J Clin Oncol (2002) 1.39
Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries. Arterioscler Thromb (1993) 1.38
Functional and morphological changes in the pancreatic remnant following pancreaticoduodenectomy with pancreaticogastric anastomosis. Br J Surg (2000) 1.37
Suppression of in vitro antibody synthesis by immunoglobulin-binding factor. J Exp Med (1975) 1.37
Role of ICAM-1 (CD54) in the development of murine cerebral malaria. Microbes Infect (1999) 1.37
Prevention of venous thromboembolism after total knee replacement by high-dose aspirin or intermittent calf and thigh compression. Br Med J (1980) 1.37
Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood (1993) 1.35
Soluble mediators of T-B interaction. Eur J Immunol (1973) 1.34
Purification and characterization of a plasminogen activator inhibitor from the histiocytic lymphoma cell line U-937. J Biol Chem (1986) 1.33
Endothelial vascular cell adhesion molecule 1 expression is suppressed by melanoma and carcinoma. J Exp Med (1995) 1.30
Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors. Blood (1987) 1.29
Risk factors for diabetes mellitus in chronic pancreatitis. Gastroenterology (2000) 1.28
Superactivation of integrin alphavbeta3 by low antagonist concentrations. J Cell Sci (2001) 1.28
Homing of hemopoietic precursor cells to the embryonic thymus: characterization of an invasive mechanism induced by chemotactic peptides. J Cell Biol (1986) 1.24
Splenic complications in chronic pancreatitis: prevalence and risk factors in a medical-surgical series of 500 patients. Br J Surg (1998) 1.24
A role for the alphavbeta3 integrin in the transmigration of monocytes. J Cell Biol (1998) 1.23
Tissue plasminogen activator: chemical and physiological aspects. Semin Thromb Hemost (1984) 1.23
Necrosis of skin induced by coumarin in a patient deficient in protein S. BMJ (1989) 1.20
Cell adhesion in the immune system. Immunol Today (1993) 1.19
[Incidence of intramural digestive system hematoma in anticoagulation. Epidemiologic study and clinical aspects of 59 cases observed in Switzerland (1970-1975)]. Schweiz Med Wochenschr (1983) 1.19
Differentiation of murine B cell precursors in agar culture. Frequency, surface marker analysis and requirements for growth of clonable pre-B cells. Eur J Immunol (1984) 1.18
Increased p53 protein content of colorectal tumours correlates with poor survival. Br J Cancer (1992) 1.13
Plasminogen activator inhibitor 1: a new prognostic marker in septic shock. Thromb Haemost (1989) 1.12
Interleukin-7 expression during mouse thymus development. Eur J Immunol (1992) 1.12
Expression of p150 in cervical neoplasia and its potential value in predicting survival. Cancer (1998) 1.11
Plasminogen activator expression in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol (1995) 1.11
Vanin-1, a novel GPI-linked perivascular molecule involved in thymus homing. Immunity (1996) 1.11
Green fluorescent protein as a novel tool to measure apoptosis and necrosis. Cytometry (2001) 1.10
The role of inflammatory and parenchymal cells in acute pancreatitis. J Pathol (2007) 1.10
Intraductal papillary and mucinous pancreatic tumour: a new extracolonic tumour in familial adenomatous polyposis. Gut (2002) 1.10
Plasminogen activators, plasminogen activator inhibitors and procoagulant analyzed in twenty human tumor cell lines. Int J Cancer (1986) 1.10
Complications following total knee replacement. Clin Orthop Relat Res (1977) 1.09
The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors. Am J Gastroenterol (2000) 1.09
Predictive factors in the outcome of pseudocysts complicating alcoholic chronic pancreatitis. Gut (1997) 1.09
Hyperglycemia-induced vasculopathy in the murine vitelline vasculature: correlation with PECAM-1/CD31 tyrosine phosphorylation state. Am J Pathol (1999) 1.09
Clopidogrel loading dose regimens: kinetic profile of pharmacodynamic response in healthy subjects. Semin Thromb Hemost (1999) 1.08
The embryonic thymus produces chemotactic peptides involved in the homing of hemopoietic precursors. Cell (1986) 1.07
Platelet-endothelial cell adhesion molecule-1 (PECAM-1/CD31) tyrosine phosphorylation state changes during vasculogenesis in the murine conceptus. Am J Pathol (1997) 1.07
Integrin alpha(v)beta(3) expression in colon carcinoma correlates with survival. Mod Pathol (2001) 1.06
Endoscopic ultrasound-guided fine-needle aspiration biopsy coupled with KRAS mutation assay to distinguish pancreatic cancer from pseudotumoral chronic pancreatitis. Endoscopy (2009) 1.06
PECAM-1/CD31 trans-homophilic binding at the intercellular junctions is independent of its cytoplasmic domain; evidence for heterophilic interaction with integrin alphavbeta3 in Cis. Mol Biol Cell (2000) 1.04
Emergence of committed B lymphoid progenitors in the developing chicken embryo. EMBO J (1992) 1.04
Isolation from human plasma of a plasminogen activator identical to urinary high molecular weight urokinase. J Clin Invest (1982) 1.04
Thromboembolic disease in patients undergoing total knee replacement. J Bone Joint Surg Am (1976) 1.03
To stick or not to stick: the new leukocyte homing paradigm. Curr Opin Cell Biol (1996) 1.03
At day 8-8.5 of mouse development the yolk sac, not the embryo proper, has lymphoid precursor potential in vivo and in vitro. Proc Natl Acad Sci U S A (1993) 1.03
The role of junctional adhesion molecule C (JAM-C) in acute pancreatitis. J Pathol (2006) 1.03
Intracellular and extracellular components involved in the formation of ventral surfaces of fibroblasts. Cold Spring Harb Symp Quant Biol (1982) 1.02
Hormonal regulation of the immune response. II. Influence of pituitary and adrenal activity on immune responsiveness in vitro. Cell Immunol (1971) 1.01
Pulmonary dysfunction and impaired granulocyte homeostasis result in poor survival of Jam-C-deficient mice. J Pathol (2007) 1.01
Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinoma. Ann Oncol (2012) 1.00
Intraductal papillary mucinous tumors of the pancreas: pancreatic resections guided by preoperative morphological assessment and intraoperative frozen section examination. Surgery (2000) 1.00
New strategies and designs in pancreatic cancer research: consensus guidelines report from a European expert panel. Ann Oncol (2011) 1.00
Suppression of mouse melanoma metastasis by EA-1, a monoclonal antibody specific for alpha 6 integrins. Cell Adhes Commun (1993) 1.00
The hemostatic mechanism after open-heart surgery. II. Frequency of abnormal platelet functions during and after extracorporeal circulation. J Thorac Cardiovasc Surg (1975) 1.00
[Intraductal papillary mucinous tumors of the pancreas. Clinical and morphological aspects in 30 patients]. Gastroenterol Clin Biol (1997) 1.00